DMC Biotechnologies Funding: $50M Raised, Series B (2021)

DMC Biotechnologies is based in Boulder. It has raised $50M in total funding. Latest round: Series B. Backed by SCG.

DMC Biotechnologies funding overview

DMC Biotechnologies is based in Boulder. DMC Biotechnologies has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2021. The round record for DMC Biotechnologies runs through 2021; nothing later has been disclosed. Investors on record include SCG.

DMC Biotechnologies at a glance

Total raised
$50M
Latest round
Series B
Latest round date
December 2021
Headquarters
Boulder
Notable investors
SCG

Frequently asked about DMC Biotechnologies funding

How much has DMC Biotechnologies raised?
DMC Biotechnologies has raised $50M in total disclosed funding across the rounds on record.
Who has invested in DMC Biotechnologies?
SCG are named among the investors backing DMC Biotechnologies.
What was the latest DMC Biotechnologies funding round?
The most recent disclosed round is a Series B, announced in December 2021.
Where is DMC Biotechnologies based?
DMC Biotechnologies is based in Boulder.
When did DMC Biotechnologies last raise?
The last disclosed DMC Biotechnologies round closed in December 2021 at Series B.

Totals shown for DMC Biotechnologies aggregate every disclosed round on file. To see how that compares, browse the companies in Boulder and the investors behind them below.

Companies related to DMC Biotechnologies (19)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026